Anti-Cancer Effects of Cyclic Peptide ALOS4 in a Human Melanoma Mouse Model.

MLA

Levi, Bar, et al. “Anti-Cancer Effects of Cyclic Peptide ALOS4 in a Human Melanoma Mouse Model.” International Journal of Molecular Sciences, vol. 22, no. 17, Sept. 2021, p. 9579. EBSCOhost, https://doi.org/10.3390/ijms22179579.

APA

Levi, B., Yacobovich, S., Kirby, M., Becker, M., Agranyoni, O., Redko, B., Gellerman, G., Pinhasov, A., Koman, I., & Nesher, E. (2021). Anti-Cancer Effects of Cyclic Peptide ALOS4 in a Human Melanoma Mouse Model. International Journal of Molecular Sciences, 22(17), 9579. https://doi.org/10.3390/ijms22179579

Chicago

Levi, Bar, Shiri Yacobovich, Michael Kirby, Maria Becker, Oryan Agranyoni, Boris Redko, Gary Gellerman, Albert Pinhasov, Igor Koman, and Elimelech Nesher. 2021. “Anti-Cancer Effects of Cyclic Peptide ALOS4 in a Human Melanoma Mouse Model.” International Journal of Molecular Sciences 22 (17): 9579. doi:10.3390/ijms22179579.